COVID-19’s death rate in the U.S. could spike as new cases soar
A crush of cases could test gains made with treatments and understanding of the disease
Christopher Petrilli, an internal medicine doctor in New York City, cared for hospitalized COVID-19 patients when the city was at the epicenter of the U.S. pandemic in the early spring. It was “all hands on deck,” he recalls.
So many COVID-19 patients were admitted to his hospital system, NYU Langone Health, during that surge — 1,724 adults in March and 2,305 in April — that “everyone was pitching in to do whatever they could to help,” he says. By August, the number of COVID-19 patients had dropped considerably, to a more manageable 134.
Over that time, the mortality rate dropped too: from 25.6 percent in March to 7.6 percent in August, Petrilli and his colleagues report online October 23 in the Journal of Hospital Medicine. The team’s calculation took into account the patients’ age, sex, race and ethnicity, past medical history and severity of illness. That way, it was clear the decrease in the death rate wasn’t just due, for example, to younger and healthier patients being admitted over the summer (SN: 9/9/20).
New York City wasn’t alone. The COVID-19 death rate has fallen across the United States as a whole. A cruder measurement — simply dividing the number of deaths by the number of cases — finds the country’s rate dropped from 6.7 percent in April to 1.9 percent in September, according to data from the U.S. Centers for Disease Control and Prevention.